156 related articles for article (PubMed ID: 37276848)
21. The occurrence of chronic lymphocytic leukemia after chronic phase of chronic myeloid leukemia: case report and literature review.
Crişan AM; BădeliŢă SN; Jardan C; Vasilache ED; Dobrea CM; Gheorghe A; Tălmaci R; Arion CV; Bardaş A; Găman AM; Coriu D
Rom J Morphol Embryol; 2015; 56(3):1145-51. PubMed ID: 26662151
[TBL] [Abstract][Full Text] [Related]
22. Watch and Wait in Lebanese Chronic Lymphocytic Leukemia Patients: How Relevant is it?
Lutfallah AA; Kourie HR; Eid R; Farhat F; Ghosn M; Kattan J
Asian Pac J Cancer Prev; 2016; 17(1):215-7. PubMed ID: 26838212
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kyasa MJ; Parrish RS; Schichman SA; Zent CS
Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Scarfò L; Chatzikonstantinou T; Rigolin GM; Quaresmini G; Motta M; Vitale C; Garcia-Marco JA; Hernández-Rivas JÁ; Mirás F; Baile M; Marquet J; Niemann CU; Reda G; Munir T; Gimeno E; Marchetti M; Quaglia FM; Varettoni M; Delgado J; Iyengar S; Janssens A; Marasca R; Ferrari A; Cuéllar-García C; Itchaki G; Špaček M; De Paoli L; Laurenti L; Levin MD; Lista E; Mauro FR; Šimkovič M; Van Der Spek E; Vandenberghe E; Trentin L; Wasik-Szczepanek E; Ruchlemer R; Bron D; De Paolis MR; Del Poeta G; Farina L; Foglietta M; Gentile M; Herishanu Y; Herold T; Jaksic O; Kater AP; Kersting S; Malerba L; Orsucci L; Popov VM; Sportoletti P; Yassin M; Pocali B; Barna G; Chiarenza A; Dos Santos G; Nikitin E; Andres M; Dimou M; Doubek M; Enrico A; Hakobyan Y; Kalashnikova O; Ortiz Pareja M; Papaioannou M; Rossi D; Shah N; Shrestha A; Stanca O; Stavroyianni N; Strugov V; Tam C; Zdrenghea M; Coscia M; Stamatopoulos K; Rossi G; Rambaldi A; Montserrat E; Foà R; Cuneo A; Ghia P
Leukemia; 2020 Sep; 34(9):2354-2363. PubMed ID: 32647324
[TBL] [Abstract][Full Text] [Related]
25. Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
Carli G; Visco C; Falisi E; Perbellini O; Novella E; Giaretta I; Ferrarini I; Sandini A; Alghisi A; Ambrosetti A; Rodeghiero F
Ann Hematol; 2016 May; 95(6):863-70. PubMed ID: 27001309
[TBL] [Abstract][Full Text] [Related]
26. Unusual complications in the management of chronic lymphocytic leukemia.
Gordon MJ; Ferrajoli A
Am J Hematol; 2022 Nov; 97 Suppl 2():S26-S34. PubMed ID: 35491515
[TBL] [Abstract][Full Text] [Related]
27. Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems.
deAndrés-Galiana EJ; Fernández-Martínez JL; Luaces O; Del Coz JJ; Huergo-Zapico L; Acebes-Huerta A; González S; González-Rodríguez AP
J Biomed Inform; 2016 Apr; 60():342-51. PubMed ID: 26956213
[TBL] [Abstract][Full Text] [Related]
28. Frequency and timing of other primary cancers in patients with chronic lymphocytic leukemia (CLL): a 17-year longitudinal study.
Akhtar OS; Groman A; Singh A; Ghione P; Lund I; Hernandez-Ilizaliturri FJ; Torka P
Leuk Lymphoma; 2022 May; 63(5):1127-1136. PubMed ID: 35152821
[TBL] [Abstract][Full Text] [Related]
29. The neurologic complications of B-cell chronic lymphocytic leukemia.
Bower JH; Hammack JE; McDonnell SK; Tefferi A
Neurology; 1997 Feb; 48(2):407-12. PubMed ID: 9040730
[TBL] [Abstract][Full Text] [Related]
30. Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience.
Laurenti L; Autore F; Innocenti I; Vannata B; Piccirillo N; Sorà F; Speziale D; Pompili M; Efremov D; Sica S
Leuk Lymphoma; 2015; 56(10):2841-6. PubMed ID: 25682966
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune complications in chronic lymphocytic leukaemia (CLL).
Zent CS; Kay NE
Best Pract Res Clin Haematol; 2010 Mar; 23(1):47-59. PubMed ID: 20620970
[TBL] [Abstract][Full Text] [Related]
32. Granulomatous interstitial nephritis secondary to chronic lymphocytic leukemia/small lymphocytic lymphoma.
Nasr SH; Shanafelt TD; Hanson CA; Fidler ME; Cornell LD; Sethi S; Chaffee KG; Morris J; Leung N
Ann Diagn Pathol; 2015 Jun; 19(3):130-6. PubMed ID: 25795422
[TBL] [Abstract][Full Text] [Related]
33. Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
Visco C; Ruggeri M; Laura Evangelista M; Stasi R; Zanotti R; Giaretta I; Ambrosetti A; Madeo D; Pizzolo G; Rodeghiero F
Blood; 2008 Feb; 111(3):1110-6. PubMed ID: 17986663
[TBL] [Abstract][Full Text] [Related]
34. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune hemolytic anemia (AIHA) associated with chronic lymphocytic leukemia in the current era of targeted therapy.
Molica S; Polliack A
Leuk Res; 2016 Nov; 50():31-36. PubMed ID: 27657651
[TBL] [Abstract][Full Text] [Related]
36. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
[TBL] [Abstract][Full Text] [Related]
37. [Chronic lymphocytic and myeloid leukemia in the same patient].
Gregersen H; Drewes AM; Asschenfeldt PB; Laursen JC
Ugeskr Laeger; 1995 Nov; 157(45):6274-5. PubMed ID: 7491723
[TBL] [Abstract][Full Text] [Related]
38. Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients.
Parikh SA; Rabe KG; Call TG; Zent CS; Habermann TM; Ding W; Leis JF; Schwager SM; Hanson CA; Macon WR; Kay NE; Slager SL; Shanafelt TD
Br J Haematol; 2013 Sep; 162(6):774-82. PubMed ID: 23841899
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine.
Di Raimondo F; Giustolisi R; Cacciola E; O'Brien S; Kantarjian H; Robertson LB; Keating MJ
Leuk Lymphoma; 1993 Sep; 11(1-2):63-8. PubMed ID: 8220155
[TBL] [Abstract][Full Text] [Related]
40. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
Strati P; Caligaris-Cappio F
Curr Opin Oncol; 2011 Sep; 23(5):455-60. PubMed ID: 21681094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
